subgroup of
drug)
→
ReceivesAction
→
approved in canada
| Typicality: | 0.287 |
| Saliency: | 0.088 |
| for the treatment of multiple sclerosis | 2 | purpose |
| prescription drug → be approved in → canada | 4 |
| negative | neutral | positive |
| 0.119 | 0.583 | 0.298 |
| Raw frequency | 4 |
| Normalized frequency | 0.088 |
| Modifier score | 0.500 |
| Perplexity | 68.870 |